10-14926856-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BS2_SupportingBA1
This summary comes from the ClinGen Evidence Repository: The NM_001033855.3:c.959C>G variant in DCLRE1C is a missense variant predicted to cause substitution of serine by cysteine at amino acid 320 (p.Ser320Cys). This variant has an allele frequency of 0.03553 in the African / African American population in gnomAD, which is above the threshold for BA1 set by the ClinGen SCID VCEP for DCLRE1C (>0.00346). In addition, 16 adult homozygous individuals with this variant are present in gnomAD v2.1.1 (in African/African American population)(BS2_Supporting).In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG criteria applied: BA1 and BS2_Supporting as specified by the ClinGen SCID VCEP (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA290573/MONDO:0011225/116
Frequency
Consequence
NM_001033855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCLRE1C | NM_001033855.3 | c.959C>G | p.Ser320Cys | missense_variant | 11/14 | ENST00000378278.7 | NP_001029027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCLRE1C | ENST00000378278.7 | c.959C>G | p.Ser320Cys | missense_variant | 11/14 | 1 | NM_001033855.3 | ENSP00000367527 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1583AN: 152114Hom.: 23 Cov.: 31
GnomAD3 exomes AF: 0.00275 AC: 691AN: 251342Hom.: 10 AF XY: 0.00200 AC XY: 272AN XY: 135842
GnomAD4 exome AF: 0.00110 AC: 1607AN: 1460850Hom.: 20 Cov.: 30 AF XY: 0.000959 AC XY: 697AN XY: 726808
GnomAD4 genome AF: 0.0104 AC: 1583AN: 152234Hom.: 23 Cov.: 31 AF XY: 0.00958 AC XY: 713AN XY: 74422
ClinVar
Submissions by phenotype
not provided Pathogenic:1Benign:4
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 17, 2018 | This variant is associated with the following publications: (PMID: 26915675) - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | DCLRE1C: BS1, BS2 - |
Likely pathogenic, criteria provided, single submitter | research | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 27, 2020 | - - |
Severe combined immunodeficiency due to DCLRE1C deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, reviewed by expert panel | curation | ClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGen | Nov 14, 2023 | The NM_001033855.3:c.959C>G variant in DCLRE1C is a missense variant predicted to cause substitution of serine by cysteine at amino acid 320 (p.Ser320Cys). This variant has an allele frequency of 0.03553 in the African / African American population in gnomAD, which is above the threshold for BA1 set by the ClinGen SCID VCEP for DCLRE1C (>0.00346). In addition, 16 adult homozygous individuals with this variant are present in gnomAD v2.1.1 (in African/African American population)(BS2_Supporting). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG criteria applied: BA1 and BS2_Supporting as specified by the ClinGen SCID VCEP (VCEP specifications version 1). - |
Athabaskan severe combined immunodeficiency Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 12, 2019 | - - |
Histiocytic medullary reticulosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at